417 related articles for article (PubMed ID: 18063601)
1. Early diagnosis of fungal infection in immunocompromised patients.
Barnes RA
J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i3-6. PubMed ID: 18063601
[TBL] [Abstract][Full Text] [Related]
2. Prevention of fungal infections in the immunocompromised host.
Mahfouz T; Anaissie E
Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
4. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
5. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
Shao PL; Huang LM; Hsueh PR
J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
[TBL] [Abstract][Full Text] [Related]
6. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
[TBL] [Abstract][Full Text] [Related]
8. Management of immunocompromised patients with evidence of an invasive mycosis.
Walsh TJ
Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
10. The impact of the host on fungal infections.
Perfect JR
Am J Med; 2012 Jan; 125(1 Suppl):S39-51. PubMed ID: 22196208
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
12. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
Leather HL; Wingard JR
Blood Rev; 2006 Sep; 20(5):267-87. PubMed ID: 16781028
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
[TBL] [Abstract][Full Text] [Related]
14. When primary antifungal therapy fails.
Nucci M; Perfect JR
Clin Infect Dis; 2008 May; 46(9):1426-33. PubMed ID: 18419447
[TBL] [Abstract][Full Text] [Related]
15. Antifungal treatment strategies in high risk patients.
Rüping MJ; Vehreschild JJ; Cornely OA
Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
[TBL] [Abstract][Full Text] [Related]
16. Pre-emptive diagnosis and treatment of fungal infections--evaluation of a single-centre policy.
Schneider T; Halter J; Heim D; Passweg J; Stern M; Tichelli A; Weisser M; Gerull S
Clin Microbiol Infect; 2012 Feb; 18(2):189-94. PubMed ID: 21729194
[TBL] [Abstract][Full Text] [Related]
17. Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system?
de Pauw BE; Viscoli C
J Antimicrob Chemother; 2011 Jan; 66 Suppl 1():i55-58. PubMed ID: 21177405
[TBL] [Abstract][Full Text] [Related]
18. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.
Mikolajewska A; Schwartz S; Ruhnke M
Mycoses; 2012 Jan; 55(1):2-16. PubMed ID: 21554421
[TBL] [Abstract][Full Text] [Related]
19. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
Erjavec Z; Kluin-Nelemans H; Verweij PE
Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
[TBL] [Abstract][Full Text] [Related]
20. A fatal case of severe immunodeficiency associated with disseminated Merulius tremellosus infection.
Friman V; Gisslén M; Nikkari S; Stenlid J; Chryssanthou E; Petrini B
Scand J Infect Dis; 2006; 38(1):76-8. PubMed ID: 16338846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
